Business
EUROBIO SCIENTIFIC: REPLACEMENT OF A STATUTORY AUDITOR
REPLACEMENT OF A STATUTORY AUDITOR Paris, December 22, 2025 – 6:00 pm Eurobio Scientific (FR0013240934, ALERS), a leading French group in in vitro medical diagnostics and life sciences, announces the replacement of one of its statutory auditors, Endrix LYO, by RSM France, which was selected following a competitive selection process This replacement follows the resignation of Endrix LYO on December 18, 2025, motivated by the acquisition of a stake in its capital by IK Partners 1, which is also an
About this update from Eurobio-scientific Sa
[{"type":"image","alt":"Eurobio Scientific","displaySize":"","headline":null,"caption":"Eurobio Scientific","className":"","disableSlideshowImg":false,"size":{"original":{"width":250,"height":71,"url":"https://media.zenfs.com/en/globenewswire.com/f9faa06825e5acb815281cbc2a20a33c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/m45eRi4SxGSzLe.1oTz.Qw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f9faa06825e5acb815281cbc2a20a33c","width":250,"height":71}},"lazy":false},{"type":"text","content":"REPLACEMENT OF A STATUTORY AUDITOR","length":34,"tagName":"p"},{"type":"text","content":"Paris, December 22, 2025 – 6:00 pm","length":34,"tagName":"p"},{"type":"text","content":"Eurobio Scientific (FR0013240934, ALERS), a leading French group in in vitro medical diagnostics and life sciences, announces the replacement of one of its statutory auditors, Endrix LYO, by RSM France, which was selected following a competitive selection process","length":263,"tagName":"p"},{"type":"text","content":"This replacement follows the resignation of Endrix LYO on December 18, 2025, motivated by the acquisition of a stake in its capital by IK Partners 1, which is also an indirect shareholder of Eurobio Scientific.","length":210,"tagName":"p"},{"type":"text","content":"The replacement of Endrix LYO by RSM France will be proposed to the Company's shareholders at the Ordinary General Meeting to be held on January 26, 2026.","length":158,"tagName":"p"},{"type":"text","content":"The documentation for the Ordinary General Meeting of January 26, 2026 will be available on the Company's website (www.eurobio-scientific.com) under the “Investors” section.","length":177,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:641.47px;border-top:solid black 1pt;text-align:justify;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"About Eurobio ScientificEurobio Scientific is a major player in the field of specialty in vitro diagnostics. It is involved from research to marketing of diagnostic tests in the fields of transplantation, immunology and infectious diseases, and offers dedicated reagents for research laboratories, including pharmaceutical and biotechnology companies. With its numerous partnerships and strong hospital presence, Eurobio Scientific has its own extensive distribut...